Bassetti M, Spada A, Arosio M, Vallar L, Brina M, Giannattasio G
J Clin Endocrinol Metab. 1986 Jun;62(6):1093-100. doi: 10.1210/jcem-62-6-1093.
A morphological study was carried out on five mixed GH- and PRL-secreting pituitary adenomas, surgically removed from acromegalic patients with hyperprolactinemia, in order to verify whether the two hormones were contained in the same cell or in different cells. Double labeling with the protein A-gold immunotechnique was used to visualize the ultrastructural localization of the two hormones on ultrathin sections of the tumors. By means of this high resolution technique we found in all adenomas the presence of numerous (from 50-80% of the whole cell population) mammosomatotrophs, i.e. cells containing simultaneously PRL and GH. The occurrence of cells producing only GH (in four tumors) or only PRL (in one tumor) was also observed. In mixed cells GH and PRL were segregated in the same mixed granule. In one tumor granules positive only for GH together with mixed granules were found in the same cell. Immunofluorescence studies, at the light microscopic level, allowed us to clearly identify mammosomatotrophs only in two tumors. Double labeling using the gold immunotechnique appears therefore to be the most suitable experimental approach to detect the existence of mixed cells in plurihormonal adenomas. Our results support the idea that the frequency of mixed adenomas with mixed cells may be higher than that believed previously. The simultaneous presence of two hormones in the same secretory granule could explain why, in patients having mixed tumors, factors able to stimulate or inhibit the release of one hormone can also stimulate or inhibit the secretion of the other.
对5例从伴有高催乳素血症的肢端肥大症患者手术切除的混合分泌生长激素(GH)和催乳素(PRL)的垂体腺瘤进行了形态学研究,以验证这两种激素是存在于同一细胞还是不同细胞中。采用蛋白A-金免疫技术进行双重标记,以观察肿瘤超薄切片上两种激素的超微结构定位。通过这种高分辨率技术,我们在所有腺瘤中均发现了大量(占整个细胞群体的50%-80%)的乳腺生长激素细胞,即同时含有PRL和GH的细胞。还观察到了仅产生GH的细胞(在4例肿瘤中)或仅产生PRL的细胞(在1例肿瘤中)。在混合细胞中,GH和PRL分隔在同一混合颗粒中。在1例肿瘤中,同一细胞内发现了仅对GH呈阳性的颗粒以及混合颗粒。在光镜水平进行的免疫荧光研究,仅在2例肿瘤中清晰地鉴定出了乳腺生长激素细胞。因此,使用金免疫技术进行双重标记似乎是检测多激素腺瘤中混合细胞存在的最合适实验方法。我们的结果支持这样一种观点,即含有混合细胞的混合腺瘤的发生率可能高于先前认为的水平。两种激素同时存在于同一分泌颗粒中,可以解释为什么在患有混合肿瘤的患者中,能够刺激或抑制一种激素释放的因素也能刺激或抑制另一种激素的分泌。